MicroRNAs play important roles in many biological processes. Their aberrant 21 expression can have oncogenic or tumor suppressor function directly participating to 22 carcinogenesis, malignant transformation, invasiveness and metastasis. Indeed, 23 miRNA profiles can distinguish not only between normal and cancerous tissue but 24 they can also successfully classify different subtypes of a particular cancer. 25 Here, we focus on a particular class of transcripts encoding polycistronic miRNA 26 genes that yields multiple miRNA components. We describe clustered MiRNA 27 Master Regulator Analysis (ClustMMRA), a fully redesigned release of the MMRA 28 computational pipeline (MiRNA Master Regulator Analysis), developed to search for 29 clustered miRNAs potentially driving cancer molecular subtyping. Genomically 30 clustered miRNAs are frequently co-expressed to target different components of pro-31 tumorigenic signalling pathways. By applying ClustMMRA to breast cancer patient 32 data, we identified key miRNA clusters driving the phenotype of different tumor 33 subgroups. The pipeline was applied to two independent breast cancer datasets, 34 providing statistically concordant results between the two analysis. We validated in 35 cell lines the miR-199/miR-214 as a novel cluster of miRNAs promoting the triple 36 negative subtype phenotype through its control of proliferation and EMT. 37 38
Introduction

39
MicroRNAs (miRNAs) are small RNA molecules emerged as important regulators of 40 gene expression at the post-transcriptional level. They have been shown to be 41 involved in the regulation of all essential functions of the cells from differentiation and 42 proliferation to apoptosis 1 . Each miRNA possesses hundreds of target genes, and a 43 single gene can be targeted by several miRNAs 2 , giving rise to complex interaction 44 networks, currrently very partially characterized. 45 Multiple studies demonstrated the importance of miRNAs in all the cancer hallmarks 46 defined by Hanahan and Weinberg 3 and indicated that they might function as 47 oncogenes or tumor suppressors 4-7 . Further experimental evidences suggested that 48 specific miRNAs may also have a role beyond the cancer onset and directly 49 participate in cancer invasiveness and metastasis 6, 8 . Indeed, miRNA profiles can 50 distinguish not only between normal and cancerous tissue but they can also 51 successfully classify different subtypes of a particular cancer 9,10 , notably of breast 52 cancer [11] [12] [13] . 53 In this work, we focused our attention on a particular class of transcripts 54 encoding polycistronic miRNA genes that yields multiple miRNA components. A Since more than 30% of annotated human miRNAs are organized in genomic 66 clusters, we can expect to find other oncogenic / tumour suppressor polycistronic 67 miRNAs that are co-expressed to jointly regulate molecular pathways involved in 68 cancer malignancy. Existing computational approaches for the identification of 69 master miRNA regulators involved in cancer onset and subtyping are typically 70 designed to detect the effect of a single miRNA (see review in 20 ). However, miRNAs 71 have been shown to frequently act in a combined manner, jointly regulating proteins 72 in close proximity of the protein-protein interaction network 21 and functionally related 73 genes [22] [23] [24] [25] . The underlying assumption of this work is that this mode of action might 74 be true also for genomically clustered miRNAs. Indeed, it has already been shown 75 that clustered miRNAs carry out pervasive cotargeting 26 . 76 Here we present Clustered MiRNA Master Regulator Analysis (ClustMMRA), a fully 77 redesigned release of the MiRNA Master Regulator Analysis (MMRA) 25,26 pipeline, 78 developed to search for clustered miRNAs potentially driving cancer subtyping. 79 MMRA was designed for miRNA underlying tumor subtypes, a comparison 80 characterized by much lower variation than cancer versus normal conditions. The 81 results of the MMRA pipeline were experimentally validated, proposing a set of four 82 miRNAs predicted to drive the stem-like aggressive colorectal cancer subtype 27 . 83 ClustMMRA extends MMRA to a model in which multiple miRNAs belonging to the 84 same genomic cluster coordinately target functionally related genes driving the 85 phenotype of a particular cancer subtype. As the MMRA pipeline, ClustMMRA is a 86 multi-step workflow that requires in input miRNA/mRNA expression profiles from 87 matched tumor samples classified in different subtypes according to subtype-specific 88 gene signatures. The final output of ClustMMRA provides key miRNA clusters 89 contributing to the regulation of particular subtypes of the disease. 90 We tested this novel pipeline to search for oncogenic / tumour suppressor 91 polycistronic miRNAs driving breast cancer subtypes. ClustMMRA was applied to 92 two independent breast cancer datasets whose samples were previously classified 93 into four subtypes (luminal A, luminal B, HER2+ and triple negative). We obtained 94 statistically concordant results between the two analysis, identifying five clusters of 95 miRNAs with aberrant expression in a specific subtype of both datasets. Among 96 them, miR-199a/214 on chromosome 1 was found to be down-regulated in the triple 97 negative subtype and associated to EMT regulation. Functional validation in cell lines 98 confirms the regulatory effect of this cluster in shaping the triple negative subtype 99 phenotype through its control of proliferation and EMT. Overall, our computational 100 pipeline and experimental validations characterize a new genomic cluster of miRNAs 101 implicated in the TNBC phenotype that might be further explored in diagnosis and 102 therapeutic strategies. In addition, we evinced a cooperative mechanism for the 103 regulatory activity of genomically clustered miRNAs. 153 Expression data required for running ClustMMRA were pre-processed as described 154 in Methods and the signatures for breast cancer subtypes were defined using the 155 approach proposed in 38 (see Methods). We applied the ClustMMRA pipeline on 156 Curie and TCGA datasets separately. In the first step, genomically co-clustered 157 miRNAs having a subtype-specific expression were identified. In this step, 28 and 47 158 out of 131 analyzed clustered miRNAs were selected for Curie and TCGA datasets, 159 respectively (see Supplementary Table S1 ). Of these, 18 clusters were in common 160 between the two datasets (p-value<7e-04), revealing a significantly concordant 161 expression pattern of co-clustered miRNAs. Among these co-clustered and co-162 expressed miRNAs, some are differentially expressed in multiple subtypes (18 and 163 37 clusters for Curie and TCGA respectively), with 15 out of 18 and 21 out of 37 164 differentially expressed in basal-like and luminal A with opposite sign. 165 In step (ii), 10 out of 28 (Curie) and 16 out of 47 (TCGA) subtype-specific miRNA 166 clusters were found to have their predicted targets enriched in genes belonging to 167 the corresponding gene signature. The output of step (ii) (see Supplementary Table   168 S2) has an intersection of 7 elements between the two datasets (p-value <1e-05). In 169 the step (iii) of ClustMMRA, a regulon for each miRNA cluster selected in step (ii) 170 was constructed. The regulons were tested for enrichment in gene signature. 7 out of 171 10 and 9 out of 16 clusters passed this last selection step in Curie and TCGA 172 datasets, respectively. These clusters constitute the final output of ClustMMRA and 173 are reported in Table 1 . After this last step, the output in common between the two 174 datasets contains 5 clusters (p-value <8e-06). The significant overlap between 175 results obtained from the analysis of two independent datasets with ClustMMRA 176 supports the reliability of this approach. Notably, the results have an intersection with This difference between the output of the two pipelines is given by the target Supplementary Table S3 . 226 Overall, the network analysis shows a regulation of EMT, stemness and extracellular U133plus2 for mRNA) and pre-processed following the procedure described in 54 . Supplementary Table   377 S4. The reliability of these signatures were tested in two ways. First, their 378 classification performances were validated on TCGA data. We classified the TCGA 
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